Please login to the form below

Not currently logged in
Email:
Password:

BT steps in with info management system

BT has launched a new system for managing pharmaceutical records that will help pharma companies reduce their costs.

BT has launched a new system for managing pharmaceutical records that will help pharma companies reduce their costs.

The new Pharmaceutical Records and Information Management (PRIM) system developed by BT Global enables firms to centralise their information and records.

According to BT, PRIM will free up capital used on companies' IT budgets, allowing for more financial investment in R&D and marketing.

Yury Rozenman, global head of BT's pharmaceutical sector said: "We know from talking to our customers that pharmaceutical firms can spend as much as 50 per cent of their IT budget maintaining legacy systems."

"PRIM addresses increasing cost pressures by rationalising IT infrastructure and releasing capital to invest in improving the R&D pipeline."

PRIM is intended to replace outdated inefficacious legacy systems with a rationalised and less complex infrastructure, allowing pharmaceutical companies to focus on the development of drugs to treat life-threatening illnesses.

Initial implementation of PRIM has taken place in the UK and Switzerland and will become available in the USA, Germany, and Japan later in 2008.

Rozenman said: "Changing conditions point to globalisation, new competition, industry consolidation and expiring patents."

4th March 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics